VOYA Investment Management’s Avidity Biosciences RNAM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-20,348
Closed -$1.47M 2428
2025
Q4
$1.47M Sell
20,348
-323,201
-94% -$20.9M ﹤0.01% 1345
2025
Q3
$15M Sell
343,549
-5,634
-2% -$228K 0.01% 562
2025
Q2
$9.92M Buy
349,183
+17,003
+5% +$507K 0.01% 737
2025
Q1
$9.81M Sell
332,180
-14,006
-4% -$436K 0.01% 743
2024
Q4
$10.1M Buy
346,186
+3,714
+1% +$155K 0.01% 747
2024
Q3
$15.7M Buy
342,472
+112,759
+49% +$4.89M 0.02% 623
2024
Q2
$9.38M Buy
229,713
+205,192
+837% +$5.89M 0.01% 777
2024
Q1
$626K Sell
24,521
-4,762
-16% -$74.6K ﹤0.01% 1900
2023
Q4
$265K Sell
29,283
-23,504
-45% -$157K ﹤0.01% 2420
2023
Q3
$337K Buy
52,787
+700
+1% +$6.03K ﹤0.01% 2248
2023
Q2
$578K Buy
52,087
+3,534
+7% +$44.3K ﹤0.01% 2002
2023
Q1
$745K Buy
48,553
+4,051
+9% +$89.1K ﹤0.01% 1819
2022
Q4
$987K Buy
44,502
+24,866
+127% +$371K ﹤0.01% 1649
2022
Q3
$321K Buy
19,636
+1,072
+6% +$20.5K ﹤0.01% 2308
2022
Q2
$270K Buy
18,564
+3,776
+26% +$56.2K ﹤0.01% 2237
2022
Q1
$273K Hold
14,788
﹤0.01% 2216
2021
Q4
$352K Buy
14,788
+680
+5% +$16.2K ﹤0.01% 2213
2021
Q3
$347K Buy
14,108
+1,352
+11% +$29.4K ﹤0.01% 2259
2021
Q2
$315K Hold
12,756
﹤0.01% 2351
2021
Q1
$278K Buy
+12,756
New +$312K ﹤0.01% 2350

Other funds holding RNAM

VOYA Investment Management's RNAM Position: Q1 2026 in Review

VOYA Investment Management sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 20,348 shares — an estimated $1.47M sold.

VOYA Investment Management first reported a position in RNAM in Q1 2021 and held it in 20 quarters. The position peaked at $15.7M in Q3 2024. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

  • VOYA Investment Management reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
  • VOYA Investment Management sold 20,348 Avidity Biosciences shares in Q1 2026, an estimated $1.47M.
  • VOYA Investment Management first reported a position in Avidity Biosciences in Q1 2021 and held it in 20 quarters.
  • VOYA Investment Management's Avidity Biosciences position peaked at $15.7M in Q3 2024.
  • 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on VOYA Investment Management's 13F filing for Q1 2026, filed 12 May 2026.